Pressmeddelanden, rapporter och bolagsmeddelande för Curasight

Spotlight News profile image

Spotlight News

Nyhetsuppdatering från Curasight

Press release from Companies: Curasight A/S presents at Nordnet Live - Spotlight Small Cap investor conference 15 April 2021
Spotlight News profile image

Spotlight News

Nyhetsuppdatering från Curasight

Press release from Companies: CAD patent application 2,905,172 relating to uTREAT[®] is accepted for grant
Spotlight News profile image

Spotlight News

Nyhetsuppdatering från Curasight

Press release from Companies: CAD patent application 2,905,172 relating to uTREAT[®] is accepted for grant
Spotlight News profile image

Spotlight News

Nyhetsuppdatering från Curasight

Press release from Companies: CAD patent application 2,905,172 relating to uTREAT[®] is accepted for grant
Spotlight News profile image

Spotlight News

Nyhetsuppdatering från Curasight

Press release from Companies: Minutes from the Annual General Meeting in Curasight A/S
Spotlight News profile image

Spotlight News

Nyhetsuppdatering från Curasight

Press release from Companies: Curasight’s presentation at Økonomisk Ugebrev Life Science Investor Conference is now available
Spotlight News profile image

Spotlight News

Nyhetsuppdatering från Curasight

Press release from Companies: Curasight’s presentation at Økonomisk Ugebrev Life Science Investor Conference is now available
Spotlight News profile image

Spotlight News

Nyhetsuppdatering från Curasight

Press release from Companies: Notice of Annual General Meeting
Spotlight News profile image

Spotlight News

Nyhetsuppdatering från Curasight

Press release from Companies: Curasight A/S presents at Økonomisk Ugebrev Life Science Investor Conference
Spotlight News profile image

Spotlight News

Nyhetsuppdatering från Curasight

Press release from Companies: Article from Phase II study in prostate cancer now published in the March issue of Journal of Nuclear Medicine and highlighted as best clinical investigation article